Diabetes Mellitus (DM) has become a world problem that seriously affected quality of life in concerned population; however, studies concerning its etiology and therapeutics are not so satisfactory. Hyperglycemia and oxidative stress damage are two hallmarks that aggravate the progression of each other. During this process, there will generate amounts of by-products, among which advanced glycation end products (AGEs) have been demonstrated to play a pivotal role in promoting the beginning and progression of DM. AGEs may interact with its receptor named RAGE and induce a series of pathological effects, such as oxidative stress, apoptosis, and inflammation etc., and form the so-called “hyperglycemia memory”. This article aims to review the piv...
Advanced glycation end products (AGEs) are formed from the non-enzymatic reaction between reducing s...
About 246 million people worldwide had diabetes in 2007. The global figure of people with diabetes i...
Advanced glycation end products (AGEs) are a heterogeneous group of molecules produced, non-enzymati...
Diabetes Mellitus (DM) has become a world problem that seriously affected quality of life in concern...
Hyperglycemic condition in diabetes accelerates formation of advanced glycation end products (AGEs) ...
Diabetes mellitus is a predominant cause of mortality and morbidity worldwide. One of its serious he...
The products of nonenzymatic glycation and oxidation of pro-teins and lipids, the advanced glycation...
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized...
The hyperglycaemic state seen in diabetes mellitus is associated with the development of diabetes-sp...
Advanced glycation end products (AGEs) and their receptor have been implicated in the progressions o...
The globally rising incidence of Type 1 diabetes (T1D) is no longer restricted to individuals with h...
Advanced Glycation Endproducts (AGEs) are a group of heterogeneous compounds formed by the non enzym...
Cardiovascular disease is the major cause of morbidity and mortality associated with diabetes. There...
Diabetes mellitus is a common endocrine disorder characterised by hyperglycaemia and predisposes to ...
Glycation describes chemistry between reactive carbonyl and dicarbonyl compounds (including reducing...
Advanced glycation end products (AGEs) are formed from the non-enzymatic reaction between reducing s...
About 246 million people worldwide had diabetes in 2007. The global figure of people with diabetes i...
Advanced glycation end products (AGEs) are a heterogeneous group of molecules produced, non-enzymati...
Diabetes Mellitus (DM) has become a world problem that seriously affected quality of life in concern...
Hyperglycemic condition in diabetes accelerates formation of advanced glycation end products (AGEs) ...
Diabetes mellitus is a predominant cause of mortality and morbidity worldwide. One of its serious he...
The products of nonenzymatic glycation and oxidation of pro-teins and lipids, the advanced glycation...
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized...
The hyperglycaemic state seen in diabetes mellitus is associated with the development of diabetes-sp...
Advanced glycation end products (AGEs) and their receptor have been implicated in the progressions o...
The globally rising incidence of Type 1 diabetes (T1D) is no longer restricted to individuals with h...
Advanced Glycation Endproducts (AGEs) are a group of heterogeneous compounds formed by the non enzym...
Cardiovascular disease is the major cause of morbidity and mortality associated with diabetes. There...
Diabetes mellitus is a common endocrine disorder characterised by hyperglycaemia and predisposes to ...
Glycation describes chemistry between reactive carbonyl and dicarbonyl compounds (including reducing...
Advanced glycation end products (AGEs) are formed from the non-enzymatic reaction between reducing s...
About 246 million people worldwide had diabetes in 2007. The global figure of people with diabetes i...
Advanced glycation end products (AGEs) are a heterogeneous group of molecules produced, non-enzymati...